N-[(4-hydroxyphenyl)methyl]-3-(trifluoromethyl)benzamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-[(4-hydroxyphenyl)methyl]-3-(trifluoromethyl)benzamide
• 英文别名: N-(4-hydroxybenzyl)-3-(trifluoromethyl)benzamide
• 化学式: C₁₅H₁₂F₃NO₂
• 分子量: 295.261
• InChiKey: UOHDXOURGIDZIR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N-[(4-hydroxyphenyl)methyl]-3-(trifluoromethyl)benzamide 在 4-碘甲苯 、 间氯过氧苯甲酸 作用下， 反应 16.0h， 以63%的产率得到2-(3-(trifluoromethyl)phenyl)-1-oxa-3-azaspiro[4.5]deca-2,6,9-trien-8-one
  参考文献：
  名称：

  氧化脱芳香环化合成螺恶唑啉

  摘要：

  描述了含侧基酰胺的苯酚和萘酚的氧化螺环化，可以接触到不常见的螺恶唑啉化合物。这些稀有螺环是通过碘（I）/（III）催化循环制备的。

  DOI：

  10.1002/ejoc.202000840
• 作为产物：
  描述：

  3-三氟甲基苯甲酸 在 三溴化硼 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 20.0~100.0 ℃ 、607.99 kPa 条件下， 反应 5.33h， 生成 N-[(4-hydroxyphenyl)methyl]-3-(trifluoromethyl)benzamide
  参考文献：
  名称：

  Design and synthesis of 3-aminophthalazine derivatives and structural analogues as PDE5 inhibitors: anti-allodynic effect against neuropathic pain in a mouse model

  摘要：

  Neuropathic pain is a chronic pain caused by a lesion or disease affecting the somatosensory nervous system. To date, no specific treatment has been developed to cure this pain. Antidepressants and anticonvulsant drugs are used, but they do not demonstrate universal efficacy, and they often cause detrimental adverse effects. Some studies highlighted the efficacy of sildenafil, a well-known inhibitor of phosphodiesterase 5 (PDE5, (IC50=3.3 nM)), in models of pain. Based on these results, we focused our attention on MY 5445, another known PDE5 inhibitor. Homologues, isosteres and structural analogues of MY 5445 were designed and all synthesized compounds were evaluated for their inhibitory activity toward PDE5. Selectivity profiles towards other PDE1-4 isoenzymes, water solubility and stability in acidic medium of the most potent PDE5 inhibitors were determined and the aminophthalazine 16h and its mimetic 41n (3-aminoindazole) were evaluated in comparison to MY 5445 (4b) in vivo in a model of neuropathic pain induced by sciatic nerve cuffing in mice (3 and 0.5 mg/kg, ip twice a day). Both compounds showed the same efficacy on neuropathic allodynia as MY 5445, and thus produced a significant relief of mechanical hypersensitivity after 12 days of treatment. (C) 2019 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2019.05.026

文献信息

• Synthesis and antiarrhythmic and parasympatholytic properties of substituted phenols. 2. Amides
  作者：David M. Stout、W. L. Matier、Cynthia Barcelon-Yang、Robert D. Reynolds、Barry S. Brown

  DOI：10.1021/jm00376a022

  日期：1984.10

  Thirty amides patterned after the antiarrhythmic drug changrolin were synthesized and their antiarrhythmic and parasympatholytic activities were assessed. There was no correlation between antiarrhythmic and parasympatholytic activities. Several of the amides were found to be potent antiarrhythmic agents that possessed low parasympatholytic activity. All of the compounds appear to act by a class I mechanism.
• Design and synthesis of 3-aminophthalazine derivatives and structural analogues as PDE5 inhibitors: anti-allodynic effect against neuropathic pain in a mouse model
  作者：Maud Bollenbach、Claire Lugnier、Mélanie Kremer、Eric Salvat、Salim Megat、Frédéric Bihel、Jean-Jacques Bourguignon、Michel Barrot、Martine Schmitt

  DOI：10.1016/j.ejmech.2019.05.026

  日期：2019.9

  Neuropathic pain is a chronic pain caused by a lesion or disease affecting the somatosensory nervous system. To date, no specific treatment has been developed to cure this pain. Antidepressants and anticonvulsant drugs are used, but they do not demonstrate universal efficacy, and they often cause detrimental adverse effects. Some studies highlighted the efficacy of sildenafil, a well-known inhibitor of phosphodiesterase 5 (PDE5, (IC50=3.3 nM)), in models of pain. Based on these results, we focused our attention on MY 5445, another known PDE5 inhibitor. Homologues, isosteres and structural analogues of MY 5445 were designed and all synthesized compounds were evaluated for their inhibitory activity toward PDE5. Selectivity profiles towards other PDE1-4 isoenzymes, water solubility and stability in acidic medium of the most potent PDE5 inhibitors were determined and the aminophthalazine 16h and its mimetic 41n (3-aminoindazole) were evaluated in comparison to MY 5445 (4b) in vivo in a model of neuropathic pain induced by sciatic nerve cuffing in mice (3 and 0.5 mg/kg, ip twice a day). Both compounds showed the same efficacy on neuropathic allodynia as MY 5445, and thus produced a significant relief of mechanical hypersensitivity after 12 days of treatment. (C) 2019 Elsevier Masson SAS. All rights reserved.
• Spirooxazoline Synthesis by an Oxidative Dearomatizing Cyclization
  作者：M. Umair Tariq、Wesley J. Moran

  DOI：10.1002/ejoc.202000840

  日期：2020.8.31

  The oxidative spirocyclization of phenols and naphthols containing pendent amides is described that grants access to unusual spirooxazoline compounds. These rare spirocycles are prepared by an iodine(I)/(III) catalytic cycle.

  描述了含侧基酰胺的苯酚和萘酚的氧化螺环化，可以接触到不常见的螺恶唑啉化合物。这些稀有螺环是通过碘（I）/（III）催化循环制备的。